AAAAAA

   
Results: 1-16 |
Results: 16
Etoposide plus cisplatin with or without the combination of 4 '-epidoxorubicin plus cyclophosphamide in treatment of extensive small-cell lung cancer: A French federation of cancer institutes multicenter phase III randomizedstudy
Authors: Pujol, JL Daures, JP Riviere, A Quoix, E Westeel, V Quantin, X Breton, JL Lemarie, E Poudenx, M Milleron, B Moro, D Debieuvre, D Le Chevalier, T
Citation: Jl. Pujol et al., Etoposide plus cisplatin with or without the combination of 4 '-epidoxorubicin plus cyclophosphamide in treatment of extensive small-cell lung cancer: A French federation of cancer institutes multicenter phase III randomizedstudy, J NAT CANC, 93(4), 2001, pp. 300-308
Etoposide phosphate with carboplatin in the treatment of elderly patients with small-cell lung cancer: A phase II study
Authors: Quoix, E Breton, JL Daniel, C Jacoulet, P Debieuvre, D Paillot, N Kessler, R Moreau, L Coetmeur, D Lemarie, E Milleron, B
Citation: E. Quoix et al., Etoposide phosphate with carboplatin in the treatment of elderly patients with small-cell lung cancer: A phase II study, ANN ONCOL, 12(7), 2001, pp. 957-962
Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Francais de Pneumo-Cancerologie (GFPC) Protocol 95-1
Authors: Robinet, G Thomas, P Breton, JL Lena, H Gouva, S Dabouis, G Bennouna, J Souquet, PJ Balmes, P Thiberville, L Fournel, P Quoix, E Riou, R Rebattu, P Perol, M Paillotin, D Mornex, F
Citation: G. Robinet et al., Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Francais de Pneumo-Cancerologie (GFPC) Protocol 95-1, ANN ONCOL, 12(1), 2001, pp. 59-67
A left pleural effusion with a calcified tumoral mass and left hemithoracic uptake on bone scan
Authors: Quoix, E Chenard, MP Orion, B Lang-Averous, G Dopff-Kaissling, A
Citation: E. Quoix et al., A left pleural effusion with a calcified tumoral mass and left hemithoracic uptake on bone scan, LUNG CANC, 32(2), 2001, pp. 203-205
Progress in the management and outcome of small-cell lung cancer in a French region from 1981 to 1994
Authors: Lebitasy, MP Hedelin, G Purohit, A Moreau, L Klinzig, F Quoix, E
Citation: Mp. Lebitasy et al., Progress in the management and outcome of small-cell lung cancer in a French region from 1981 to 1994, BR J CANC, 85(6), 2001, pp. 808-815
Brain metastases at the time of presentation of nonsmall cell lung cancer:a multi-centric AERIO analysis of prognostic factors
Authors: Jacot, W Quantin, X Boher, JM Andre, F Moreau, L Gainet, M Depierre, A Quoix, E Le Chevalier, T Pujol, JL
Citation: W. Jacot et al., Brain metastases at the time of presentation of nonsmall cell lung cancer:a multi-centric AERIO analysis of prognostic factors, BR J CANC, 84(7), 2001, pp. 903-909
Upper respiratory tract localization of sarcoidosis: 4 cases
Authors: Oster, JP Braun, JJ Quoix, E Bourjat, P Pauli, G
Citation: Jp. Oster et al., Upper respiratory tract localization of sarcoidosis: 4 cases, REV MAL RES, 17(4), 2000, pp. 863-866
Response to the letter of B. Lebeau
Authors: Lemarie, E Quoix, E Milleron, B
Citation: E. Lemarie et al., Response to the letter of B. Lebeau, REV MAL RES, 17(3), 2000, pp. 707-707
Variables determining the prognosis of lung cancer.
Authors: Quoix, E Moreau, L
Citation: E. Quoix et L. Moreau, Variables determining the prognosis of lung cancer., REV MAL RES, 17(1), 2000, pp. 399-410
Survival of patients with resected N2 non-small-cell lung cancer: Evidencefor a subclassification and implications
Authors: Andre, F Grunenwald, D Pignon, JP Dujon, A Pujol, JL Brichon, PY Brouchet, L Quoix, E Westeel, V Le Chevalier, T
Citation: F. Andre et al., Survival of patients with resected N2 non-small-cell lung cancer: Evidencefor a subclassification and implications, J CL ONCOL, 18(16), 2000, pp. 2981-2989
Comparative prognostic value of lactate dehydrogenase and neuron-specific enolase in small-cell lung cancer patients treated with platinum-based chemotherapy
Authors: Quoix, E Purohit, A Faller-Beau, M Moreau, L Oster, JP Pauli, G
Citation: E. Quoix et al., Comparative prognostic value of lactate dehydrogenase and neuron-specific enolase in small-cell lung cancer patients treated with platinum-based chemotherapy, LUNG CANC, 30(2), 2000, pp. 127-134
Pulmonary migratory infiltrates and pachypleuritis in a patient with Crohn's disease
Authors: Faller, M Gasser, B Massard, G Pauli, G Quoix, E
Citation: M. Faller et al., Pulmonary migratory infiltrates and pachypleuritis in a patient with Crohn's disease, RESPIRATION, 67(4), 2000, pp. 459-463
Do patients with squamous cell carcinoma or adenocarcinoma of the lung have different smoking histories?
Authors: Kubina, M Hedelin, G Charloux, A Purohit, A Pauli, G Quoix, E
Citation: M. Kubina et al., Do patients with squamous cell carcinoma or adenocarcinoma of the lung have different smoking histories?, REV MAL RES, 16(4), 1999, pp. 539-549
Nature of chemotherapy in stage IV
Authors: Quoix, E
Citation: E. Quoix, Nature of chemotherapy in stage IV, REV MAL RES, 16, 1999, pp. S122-S125
Weekly systemic combination of cisplatin and interferon alpha 2a in diffuse malignant pleural mesothelioma
Authors: Purohit, A Moreau, L Dietemann, A Seibert, R Pauli, G Wihlm, JM Quoix, E
Citation: A. Purohit et al., Weekly systemic combination of cisplatin and interferon alpha 2a in diffuse malignant pleural mesothelioma, LUNG CANC, 22(2), 1998, pp. 119-125
Drugs and radiopotentiation in locally advanced non-small cell lung cancer
Authors: Quoix, E Moreau, L Oster, JP
Citation: E. Quoix et al., Drugs and radiopotentiation in locally advanced non-small cell lung cancer, TREATMENT OPTIMIZATION FOR LUNG CANCER, 1998, pp. 207-218
Risultati: 1-16 |